Loading...
Zeon Corporation
ZEOOF•PNK
Basic Materials
Chemicals - Specialty
$9.35
$0.00(0.00%)
Zeon Corporation (ZEOOF) Financial Performance & Income Statement Overview
Review Zeon Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.04%
↑ 10.04%
Operating Income Growth
38.53%
↑ 38.53%
Net Income Growth
-15.76%
↓ 15.76%
Operating Cash Flow Growth
-56.17%
↓ 56.17%
Operating Margin
6.89%
↑ 6.89%
Gross Margin
28.11%
↑ 28.11%
Net Profit Margin
6.23%
↑ 6.23%
ROE
7.24%
↑ 7.24%
ROIC
7.59%
↑ 7.59%
Zeon Corporation (ZEOOF) Income Statement & Financial Overview
Review Zeon Corporation's (ZEOOF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $105.21B | $102.08B | $107.25B | $106.11B |
| Cost of Revenue | $77.31B | $72.92B | $76.87B | $75.52B |
| Gross Profit | $27.91B | $29.16B | $30.37B | $30.58B |
| Gross Profit Ratio | $0.27 | $0.29 | $0.28 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $22.78B | $22.32B | $22.80B | $21.79B |
| Operating Expenses | $22.78B | $21.79B | $22.80B | $21.54B |
| Total Costs & Expenses | $100.09B | $94.71B | $99.67B | $97.06B |
| Interest Income | $97.00M | $71.00M | $73.00M | $71.00M |
| Interest Expense | $48.00M | -$738.00M | $40.00M | $22.00M |
| Depreciation & Amortization | $5.23B | $5.03B | $4.74B | $5.03B |
| EBITDA | $11.21B | $11.83B | $9.91B | $15.60B |
| EBITDA Ratio | $0.11 | $0.12 | $0.09 | $0.15 |
| Operating Income | $5.13B | $7.37B | $7.57B | $9.04B |
| Operating Income Ratio | $0.05 | $0.07 | $0.07 | $0.09 |
| Other Income/Expenses (Net) | $692.00M | $3.34B | -$2.19B | $1.97B |
| Income Before Tax | $5.82B | $10.71B | $5.38B | $11.007B |
| Income Before Tax Ratio | $0.06 | $0.10 | $0.05 | $0.10 |
| Income Tax Expense | -$275.00M | $2.86B | $1.26B | $2.71B |
| Net Income | $6.07B | $7.83B | $4.11B | $8.19B |
| Net Income Ratio | $0.06 | $0.08 | $0.04 | $0.08 |
| EPS | $30.69 | $38.46 | $19.45 | $38.77 |
| Diluted EPS | $30.69 | $38.46 | $19.44 | $38.75 |
| Weighted Avg Shares Outstanding | $197.74M | $203.60M | $211.26M | $211.35M |
| Weighted Avg Shares Outstanding (Diluted) | $197.74M | $203.62M | $211.44M | $211.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan